富士製薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/26 | 1,615 | 1,660 | 1,615 | 1,638 | +31 | +1.9% | 19,600 |
2018/12/25 | 1,661 | 1,678 | 1,603 | 1,607 | -129 | -7.4% | 31,800 |
2018/12/21 | 1,747 | 1,761 | 1,697 | 1,736 | -26 | -1.5% | 51,700 |
2018/12/20 | 1,768 | 1,785 | 1,750 | 1,762 | -22 | -1.2% | 42,400 |
2018/12/19 | 1,755 | 1,802 | 1,740 | 1,784 | +24 | +1.4% | 33,300 |
2018/12/18 | 1,850 | 1,850 | 1,760 | 1,760 | -98 | -5.3% | 23,800 |
2018/12/17 | 1,851 | 1,864 | 1,835 | 1,858 | -6 | -0.3% | 19,500 |
2018/12/14 | 1,905 | 1,910 | 1,856 | 1,864 | -26 | -1.4% | 28,000 |
2018/12/13 | 1,873 | 1,907 | 1,873 | 1,890 | +17 | +0.9% | 32,600 |
2018/12/12 | 1,866 | 1,874 | 1,851 | 1,873 | +18 | +1% | 15,800 |
2018/12/11 | 1,857 | 1,879 | 1,835 | 1,855 | +10 | +0.5% | 28,800 |
2018/12/10 | 1,846 | 1,853 | 1,822 | 1,845 | -28 | -1.5% | 16,500 |
2018/12/07 | 1,877 | 1,914 | 1,851 | 1,873 | +21 | +1.1% | 37,500 |
2018/12/06 | 1,851 | 1,855 | 1,799 | 1,852 | +1 | +0.1% | 47,600 |
2018/12/05 | 1,809 | 1,884 | 1,800 | 1,851 | +2 | +0.1% | 28,200 |
2018/12/04 | 1,950 | 1,950 | 1,845 | 1,849 | -103 | -5.3% | 20,100 |
2018/12/03 | 1,915 | 1,962 | 1,914 | 1,952 | +29 | +1.5% | 24,900 |
2018/11/30 | 1,884 | 1,931 | 1,879 | 1,923 | +54 | +2.9% | 42,100 |
2018/11/29 | 1,896 | 1,897 | 1,848 | 1,869 | -27 | -1.4% | 22,300 |
2018/11/28 | 1,855 | 1,897 | 1,847 | 1,896 | +55 | +3% | 36,000 |
2018/11/27 | 1,832 | 1,843 | 1,818 | 1,841 | +29 | +1.6% | 18,000 |
2018/11/26 | 1,836 | 1,838 | 1,800 | 1,812 | -24 | -1.3% | 33,800 |
2018/11/22 | 1,813 | 1,847 | 1,798 | 1,836 | +23 | +1.3% | 17,400 |
2018/11/21 | 1,810 | 1,827 | 1,786 | 1,813 | -29 | -1.6% | 46,500 |
2018/11/20 | 1,887 | 1,887 | 1,839 | 1,842 | -47 | -2.5% | 14,200 |
2018/11/19 | 1,881 | 1,898 | 1,846 | 1,889 | +16 | +0.9% | 22,900 |
2018/11/16 | 1,835 | 1,891 | 1,801 | 1,873 | +49 | +2.7% | 37,000 |
2018/11/15 | 1,851 | 1,858 | 1,794 | 1,824 | -52 | -2.8% | 30,900 |
2018/11/14 | 1,871 | 1,898 | 1,838 | 1,876 | +15 | +0.8% | 35,600 |
2018/11/13 | 1,836 | 1,866 | 1,801 | 1,861 | -23 | -1.2% | 35,300 |
2018/11/12 | 1,800 | 1,887 | 1,784 | 1,884 | +55 | +3% | 87,500 |
2018/11/09 | 1,799 | 1,849 | 1,790 | 1,829 | +33 | +1.8% | 47,100 |
2018/11/08 | 1,767 | 1,796 | 1,753 | 1,796 | +62 | +3.6% | 32,100 |
2018/11/07 | 1,754 | 1,754 | 1,725 | 1,734 | -20 | -1.1% | 21,700 |
2018/11/06 | 1,720 | 1,769 | 1,720 | 1,754 | +20 | +1.2% | 16,600 |
2018/11/05 | 1,728 | 1,755 | 1,716 | 1,734 | -9 | -0.5% | 28,900 |
2018/11/02 | 1,745 | 1,745 | 1,707 | 1,743 | +17 | +1% | 35,800 |
2018/11/01 | 1,774 | 1,774 | 1,715 | 1,726 | -48 | -2.7% | 26,400 |
2018/10/31 | 1,749 | 1,775 | 1,738 | 1,774 | +39 | +2.2% | 27,800 |
2018/10/30 | 1,657 | 1,737 | 1,657 | 1,735 | +78 | +4.7% | 43,500 |
2018/10/29 | 1,701 | 1,715 | 1,652 | 1,657 | -38 | -2.2% | 28,400 |
2018/10/26 | 1,743 | 1,762 | 1,678 | 1,695 | -40 | -2.3% | 36,800 |
2018/10/25 | 1,780 | 1,780 | 1,719 | 1,735 | -51 | -2.9% | 42,300 |
2018/10/24 | 1,790 | 1,790 | 1,736 | 1,786 | +15 | +0.8% | 24,400 |
2018/10/23 | 1,842 | 1,842 | 1,766 | 1,771 | -74 | -4% | 43,900 |
2018/10/22 | 1,837 | 1,849 | 1,790 | 1,845 | +7 | +0.4% | 37,300 |
2018/10/19 | 1,799 | 1,838 | 1,769 | 1,838 | +31 | +1.7% | 34,500 |
2018/10/18 | 1,867 | 1,867 | 1,805 | 1,807 | -54 | -2.9% | 29,300 |
2018/10/17 | 1,830 | 1,878 | 1,830 | 1,861 | +65 | +3.6% | 45,600 |
2018/10/16 | 1,777 | 1,820 | 1,774 | 1,796 | +19 | +1.1% | 33,500 |
1551~
1600
件表示中 / 6949件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
富士製薬 | 130,200円 | +15.7% | +5.3% | 3.49% | 9.41倍 | 0.70倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
タウンズ | 50,800円 | +4.6% | +6.1% | 5.51% | 8.64倍 | 3.19倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
生化学 | 72,200円 | +9.2% | +39.0% | 4.16% | 23.88倍 | 0.52倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。2種のヒアルロン酸製剤は科研と参天が販売 |
ダイト | 207,000円 | +4.5% | -33.7% | 3.38% | 20.70倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ヘリオス | 30,300円 | +150.0% | - | 0.00% | - | 14.90倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム